Navigation Links
InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
Date:9/17/2009

R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes pirfenidone for which a Phase 3 program in patients with IPF (CAPACITY) has been completed and the compound is currently in the pre-registration stage. The company also has a research program focused on a pirfenidone analog named ITMN-520. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as RG7227 at Roche) expected to enter Phase 2b in the summer of 2009 and a second-generation HCV protease inhibitor research program. For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

About National Jewish Health

National Jewish Health is known worldwide for treatment of patients with respiratory, immune and related disorders, and for groundbreaking medical research. Founded in 1899 as a nonprofit hospital, National Jewish Health provides the best integrated and innovative care for patients and their families; seeks to understand and find cures for the diseases we research; and educates and trains the next generation of healthcare professionals to be leaders in medicine and science. We pursue this vision by pioneering individualized medicine programs which embrace the paradigm shift from reactive medicine to proactive, personalized healthcare. For 11 consecutive years, U.S. News & World Report has ranked National Jewish Health the No. 1 respiratory hospital in the nation. Scholarly publisher Thomson Scientific has ranked National Jewish among the 25 most influential research institutions in the world in its areas of focus. Further information can be found by visiting www.nationaljewish.org.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 05, 2015 Research and ... announced the addition of the "Separation ... their offering. Macromolecules which include ... separation or are broken into smaller molecules, ... This separation requires various advanced systems like ...
(Date:5/5/2015)... 2015  Renova™ Therapeutics, a biopharmaceutical company developing ... other chronic diseases, has engaged RAND Health Advisory ... reflect the healthcare patterns of multiple advanced heart ... used to characterize the impact the company,s lead ... groups of patients and the overall health care ...
(Date:5/5/2015)... BELLINGHAM, Washington, and WASHINGTON, D.C., USA (PRWEB) May 05, ... today on U.S. export regulations covering a wide range ... the industry say are hampering global competitiveness of U.S. ... will host a webinar on 12 May ... Category XII, which governs the commodities covered by International ...
(Date:5/5/2015)... , May 5, 2015 CytomX, a biotechnology ... today announced that Sean McCarthy , D. Phil., ... Antibody Day in New York ... McCarthy will present an overview of CytomX,s Probody pipeline, ... conjugate programs. About CytomX Therapeutics CytomX ...
Breaking Biology Technology:Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4
... , , , PRINCETON, ... Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced ... Officer, will present at the Rodman & Renshaw 11th Annual ... at 4:55 PM on Thursday, September 10, 2009 in the ...
... - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that ... , , - Rodman & Renshaw 11th ... September 10, 2009 at 12:30 p.m. Eastern Time in the Fahnestock Salon, ... Hotel in New York City., - Thomas ...
... 2 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Robert W. Baird & Co. 2009 Health Care Conference ... 2009 Health Care Conference in New York, New York, on September 9, 2009 ... Thomas Weisel Partners Healthcare Conference , Subsequently, Onyx will ...
Cached Biology Technology:DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 2DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 3DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 4OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 2Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences 2
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications Corp. ... global provider of Software Defined Network Architecture (ET Software ... total revenue of approximately $20.4 million for the year ... $19.5 million for the year ended December 31, 2013. ... the Company had completed its multi-year transition away from ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... built at Scripps Institution of Oceanography at UC San ... state of all world oceans simultaneously is approaching its ... network of sensor-bearing profiling floats measures ocean water temperature, ... The Argo Steering Committee, the international panel of scientists ...
... living and dead organisms could serve as a relatively fast, ... ecosystems. The University of Chicago,s Susan Kidwell explains how measuring ... ecological tool in the Oct. 26 early online edition of ... affect ecosystems in many different ways, but the effects of ...
... and their colleagues have uncovered evidence of when Earth ... the one we breathe today. The study suggests ... of reverse-greenhouse effect 500 million years ago that cooled ... a burst of oxygen into the atmosphere. That ...
Cached Biology News:Unprecedented global measurement network achieves full coverage of oceans 2Unprecedented global measurement network achieves full coverage of oceans 3Dead clams tell many tales 2Dead clams tell many tales 3Dead clams tell many tales 4Researchers find origin of 'breathable' atmosphere half a billion years ago 2Researchers find origin of 'breathable' atmosphere half a billion years ago 3Researchers find origin of 'breathable' atmosphere half a billion years ago 4
... recognizes murine IRF7 protein, and ... related IRF proteins. Reactivity of ... protein was confirmed by western ... cells transfected with IRF7. Reactivity ...
...
EMBP (FL-222)...
Rabbit anti-T-box 6...
Biology Products: